Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CereDRAIN is a Norwegian medical technology company developing an innovative automated system for the drainage of cerebrospinal fluid (CSF). The company's primary focus is on improving the management of patients with increased intracranial pressure, such as those suffering from hydrocephalus or traumatic brain injury. Their technology aims to replace manual, gravity-based external ventricular drainage (EVD) systems with a precise, sensor-controlled automated solution that enhances patient safety and reduces the risk of complications like over-drainage or infection. By providing real-time monitoring and controlled drainage, CereDRAIN seeks to modernize neurocritical care and improve clinical outcomes for neurosurgical patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CereDRAIN.